4Suppliers
0Customers
3Debt Items
20Related Chains

aTyr Pharma, Inc. Suppliers

TickerNameConfidenceEvidence
CDMOS CDMOS 90% we outsource our manufacturing of clinical trial materials to CDMOs
CROS CROS 90% We primarily outsource our clinical trial administration to CROs
INVESTIGATIVE-SITES INVESTIGATIVE-SITES 80% costs incurred under clinical trial agreements with CROs and investigative sites
LABORATORY-SUPPLIES LABORATORY-SUPPLIES 70% costs for laboratory supplies

aTyr Pharma, Inc. Customers

No clients on recordNo downstream customers found in our database for aTyr Pharma, Inc..

aTyr Pharma, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATYR-DEBT Debt stack $11.7M 90% Market cache reports total debt of $11.7M.
ATYR-DEBT-7966 Xbrl Convertible 90% xbrl convertible detail from xbrl 2015-12-31.
ATYR-DEBT-7965 Warrants outstanding: 263000 90% xbrl warrant detail from xbrl 2017-12-31.

aTyr Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for aTyr Pharma, Inc..

aTyr Pharma, Inc. Ownership

HolderNameConfidenceEvidence
ATYR-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 113 tracked holders.

aTyr Pharma, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
KDK Kodiak AI, Inc. 100.00 2
DNLI Denali Therapeutics Inc. 100.00 2
TEM Tempus AI, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
BNTC Benitec Biopharma Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2
CABA Cabaletta Bio, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
ELVN Enliven Therapeutics, Inc. 100.00 2
BIAF bioAffinity Technologies, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
IMNM Immunome, Inc. 100.00 2
HOWL Werewolf Therapeutics, Inc. 100.00 2
TPST Tempest Therapeutics, Inc. 100.00 2
GH Guardant Health, Inc. 100.00 2
JANX Janux Therapeutics, Inc. 100.00 2